From Simulation to Strategy: When Autonomous Systems Start Auditing Themselves
A lab is full of reviews. A candidate molecule is screened, criticized, scored, filtered, re-ranked, re-tested, and then quietly abandoned because one property looked promising while three others looked inconvenient. Drug discovery has never lacked opinions. It has lacked a clean way to convert those opinions into a machine-readable optimization process. That is the useful point in MAC-AMP: A Closed-Loop Multi-Agent Collaboration System for Multi-Objective Antimicrobial Peptide Design.1 The paper is easy to misread as another “LLM designs molecules” story. That would be tidy, familiar, and slightly wrong. ...